| Application number | Title of the application | Filing Date | Status |
|---|
| 09/937473 | Antisense modulation of interleukin-5 signal transduction | Jan 27, 2002 | Abandoned |
Array
(
[id] => 1375969
[patent_doc_number] => 06562947
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-13
[patent_title] => 'Human skeletal muscle-specific ubiquitin-conjugating enzyme'
[patent_app_type] => B2
[patent_app_number] => 09/976165
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 47121
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562947.pdf
[firstpage_image] =>[orig_patent_app_number] => 09976165
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/976165 | Human skeletal muscle-specific ubiquitin-conjugating enzyme | Oct 14, 2001 | Issued |
| 09/958186 | Antisense oligonucleotide compositions and methods for the modulation of jnk proteins | Oct 3, 2001 | Abandoned |
| 09/857299 | Antisense modulation of cellular inhibitor of apoptosis-2 expression | Oct 3, 2001 | Abandoned |
| 09/856748 | Antisense modulation of interleukin-15 expression | Sep 23, 2001 | Abandoned |
Array
(
[id] => 1449760
[patent_doc_number] => 06455308
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Antisense modulation of serum amyloid A4 expression'
[patent_app_type] => B1
[patent_app_number] => 09/920672
[patent_app_country] => US
[patent_app_date] => 2001-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26853
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455308.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920672
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920672 | Antisense modulation of serum amyloid A4 expression | Jul 31, 2001 | Issued |
Array
(
[id] => 1458583
[patent_doc_number] => 06426221
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-30
[patent_title] => 'Antisense modulation of RIP2 expression'
[patent_app_type] => B1
[patent_app_number] => 09/920663
[patent_app_country] => US
[patent_app_date] => 2001-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26929
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/426/06426221.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920663
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920663 | Antisense modulation of RIP2 expression | Jul 31, 2001 | Issued |
Array
(
[id] => 1588557
[patent_doc_number] => 06482644
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Antisense modulation of dual specific phosphatase 8 expression'
[patent_app_type] => B1
[patent_app_number] => 09/920668
[patent_app_country] => US
[patent_app_date] => 2001-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27188
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482644.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920668
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920668 | Antisense modulation of dual specific phosphatase 8 expression | Jul 31, 2001 | Issued |
Array
(
[id] => 1507133
[patent_doc_number] => 06440739
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Antisense modulation of glioma-associated oncogene-2 expression'
[patent_app_type] => B1
[patent_app_number] => 09/907843
[patent_app_country] => US
[patent_app_date] => 2001-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28762
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440739.pdf
[firstpage_image] =>[orig_patent_app_number] => 09907843
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/907843 | Antisense modulation of glioma-associated oncogene-2 expression | Jul 16, 2001 | Issued |
Array
(
[id] => 6774191
[patent_doc_number] => 20030017529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/891498
[patent_app_country] => US
[patent_app_date] => 2001-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19150
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017529.pdf
[firstpage_image] =>[orig_patent_app_number] => 09891498
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/891498 | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | Jun 26, 2001 | Abandoned |
| 09/868534 | Antisense modulation of sentrin expression | Jun 14, 2001 | Abandoned |
| 09/868278 | Antisense modulation of akt-1 expression | Jun 14, 2001 | Abandoned |
Array
(
[id] => 6361382
[patent_doc_number] => 20020058638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Antisense inhibition of PTEN expression'
[patent_app_type] => new
[patent_app_number] => 09/878582
[patent_app_country] => US
[patent_app_date] => 2001-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27453
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058638.pdf
[firstpage_image] =>[orig_patent_app_number] => 09878582
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/878582 | Antisense inhibition of PTEN expression | Jun 10, 2001 | Abandoned |
| 09/857267 | Antisense modulation of g alpha 11 expression | May 31, 2001 | Abandoned |
Array
(
[id] => 6898539
[patent_doc_number] => 20010046704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Methods and compositions to activate genes in cells'
[patent_app_type] => new
[patent_app_number] => 09/864001
[patent_app_country] => US
[patent_app_date] => 2001-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5870
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20010046704.pdf
[firstpage_image] =>[orig_patent_app_number] => 09864001
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/864001 | Methods and compositions to activate genes in cells | May 22, 2001 | Abandoned |
Array
(
[id] => 1544925
[patent_doc_number] => 06444466
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Antisense modulation of helicase-moi expression'
[patent_app_type] => B1
[patent_app_number] => 09/853768
[patent_app_country] => US
[patent_app_date] => 2001-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34048
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444466.pdf
[firstpage_image] =>[orig_patent_app_number] => 09853768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/853768 | Antisense modulation of helicase-moi expression | May 9, 2001 | Issued |
Array
(
[id] => 1532167
[patent_doc_number] => 06410325
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Antisense modulation of phospholipase A2, group VI (Ca2-independent) expression'
[patent_app_type] => B1
[patent_app_number] => 09/851896
[patent_app_country] => US
[patent_app_date] => 2001-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25057
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410325.pdf
[firstpage_image] =>[orig_patent_app_number] => 09851896
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/851896 | Antisense modulation of phospholipase A2, group VI (Ca2-independent) expression | May 8, 2001 | Issued |
Array
(
[id] => 1577844
[patent_doc_number] => 06448081
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-10
[patent_title] => 'Antisense modulation of interleukin 12 p40 subunit expression'
[patent_app_type] => B1
[patent_app_number] => 09/851062
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27224
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/448/06448081.pdf
[firstpage_image] =>[orig_patent_app_number] => 09851062
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/851062 | Antisense modulation of interleukin 12 p40 subunit expression | May 6, 2001 | Issued |
Array
(
[id] => 1550070
[patent_doc_number] => 06399379
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-04
[patent_title] => 'Antisense modulation of interleukin 12 p35 subunit expression'
[patent_app_type] => B1
[patent_app_number] => 09/851520
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25609
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/399/06399379.pdf
[firstpage_image] =>[orig_patent_app_number] => 09851520
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/851520 | Antisense modulation of interleukin 12 p35 subunit expression | May 6, 2001 | Issued |
Array
(
[id] => 1595204
[patent_doc_number] => 06492172
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Antisense modulation of GU protein expression'
[patent_app_type] => B1
[patent_app_number] => 09/844521
[patent_app_country] => US
[patent_app_date] => 2001-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27487
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492172.pdf
[firstpage_image] =>[orig_patent_app_number] => 09844521
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/844521 | Antisense modulation of GU protein expression | Apr 26, 2001 | Issued |
